Morbidity, mortality and spatial distribution of meningococcal disease, 1974-2007

Epidemiology and Infection

Volumn 137, Issue 11, 2009, Pages 1631-1640

  Howitz, M ^a   Lambertsen, L ^a   Simonsen, J B ^a   Christensen, J J ^a   Molbak K ^a  

^a STATENS SERUM INSTITUT   (Denmark)

Author keywords

Denmark; Meningococcal disease; Morbidity; Mortality; Neisseria meningitidis; Population density; Serogroup; Spatial distribution

Indexed keywords

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BACTERIUM ISOLATE; CHILD; DENMARK; FEMALE; HOSPITAL; HUMAN; INCIDENCE; INFANT; MAJOR CLINICAL STUDY; MALE; MENINGOCOCCOSIS; MORBIDITY; MORTALITY; NEISSERIACEAE; PHENOTYPE; POPULATION DENSITY; RISK ASSESSMENT; RISK FACTOR; SEROTYPE; SEX DIFFERENCE; URBAN RURAL DIFFERENCE; CLASSIFICATION; EPIDEMIC MENINGITIS; MICROBIOLOGY; MIDDLE AGED; NEISSERIA MENINGITIDIS; PRESCHOOL CHILD; PROPORTIONAL HAZARDS MODEL; REGISTER; SEPSIS; SEROTYPING;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; DENMARK; FEMALE; HUMANS; INCIDENCE; INFANT; MALE; MENINGITIS, MENINGOCOCCAL; MIDDLE AGED; NEISSERIA MENINGITIDIS; PROPORTIONAL HAZARDS MODELS; REGISTRIES; SEPSIS; SEROTYPING; YOUNG ADULT;

EID: 70349566434     PISSN: 09502688     EISSN: 14694409     Source Type: Journal    
DOI: 10.1017/S0950268809002428     Document Type: Article

References (37)

1. Stephens DS, Greenwood B, Brandtzaeg P. Epidemic meningitis, meningococcaemia, and Neisseria meningitidis. Lancet 2007; 369: 2196-2210.
2. EU-IBIS Network. Invasive Neisseria meningitidis in Europe 2006 (http://www.euibis.org/documents/2006- meningo.pdf). London: Health Protection Agency, 2007. Accessed 29 January 2008.
3. World Health Organization. Meningococcal disease in the African Meningitis Belt, epidemic season, 2006. Accessed 25 September 2008.
4. Trotter CL, et al. Fatal outcome from meningococcal disease -an association with meningococcal phenotype but not with reduced susceptibility to benzylpenicillin. Journal of Medical Microbiology 2002; 51: 855-860.
5. Jensen ES, et al. Neisseria meningitidis phenotypic markers and septicaemia, disease progress and casefatality rate of meningococcal disease : A 20-year population-based historical follow-up study in a Danish county. Journal of Medical Microbiology 2003; 52: 173-179.
6. Purcell B, et al. Effectiveness of antibiotics in preventing meningococcal disease after a case : Systematic review. British Medical Journal 2004; 328: 1339.
7. Baker M, et al. Household crowding a major risk factor for epidemic meningococcal disease in Auckland children. Pediatric Infectious Diseases Journal 2000; 19: 983-990.
8. Deutch S, et al. Crowding as a risk factor of meningococcal disease in Danish preschool children : A nationwide population-based case-control study. Scandinavian Journal of Infectious Diseases 2004; 36: 20-23.
9. Moodley JR, Coetzee N, Hussey G. Risk factors for meningococcal disease in Cape Town. South African Medical Journal 1999; 89: 56-59.
10. Froeschle JE. Meningococcal disease in college students. Clinical Infectious Diseases 1999; 29: 215-216.
11. Harrison LH, et al. Risk of meningococcal infection in college students. Journal of the American Medical Association 1999; 281: 1906-1910.
12. Imrey PB, et al. Outbreak of serogroup C meningococcal disease associated with campus bar patronage. American Journal of Epidemiology 1996; 143: 624-630.
13. Advisory Committee on Immunization Practices (ACIP). Meningococcal disease and college students. Morbidity and Mortality Weekly Report (Recommended Reports) 2000; 49 (RR-7): 13-20.
14. Brundage JF, et al. Meningococcal disease among United States military service members in relation to routine uses of vaccines with different serogroupspecific components, 1964-1998. Clinical Infectious Diseases 2002; 35: 1376-1381.
15. Kadlubowski M, et al. Invasive meningococcal disease at a military base in Warsaw, January 2007. Eurosurveillance 2007; 12: E070301.
16. Swain CL, Martin DR. Survival of meningococci outside of the host: Iimplications for acquisition. Epidemiology and Infection 2007; 135: 315-320.
17. Lind I, Berthelsen L. Epidemiology of meningococcal disease in Denmark 1974-1999: Contribution of the laboratory surveillance system. Epidemiology and Infection 2005; 133: 205-215.
18. Andersen J, et al. Dynamics of the meningococcal carrier state and characteristics of the carrier strains : A longitudinal study within three cohorts of military recruits. Epidemiology and Infection 1998; 121: 85-94.
19. Howitz M, et al. Lack of association between group B meningococcal disease and autoimmune disease. Clinical Infectious Diseases 2007; 45: 1327-1334.
20. Howitz MF, Samuelsson S, Molbak K. Declining incidence of meningococcal disease in Denmark, confirmed by a capture-recapture analysis for 1994 and 2002. Epidemiology and Infection 2008; 136: 1088-1095.
21. Samuelsson S. Surveillance and Prevention of Meningococcal Disease Denmark, 1980-1996 (PhD thesis). Faculty of Health Sciences, University of Southern Denmark, Odense, Denmark, 1999.
22. Danish Civil Registration System. (http://www.cpr.dk/cpr/). Accessed 9 June 2008.
23. Pedersen CB, et al. The Danish Civil Registration System. A cohort of eight million persons. Danish Medical Bulletin 2006; 53: 441-449.
24. Ethelberg S, et al. Spatial distribution and registrybased case-control analysis of Campylobacter infections in Denmark, 1991-2001. American Journal of Epidemiology 2005; 162: 1008-1015.
25. Brassier N, et al. Meningococcal meningitis and meningococcemia : Epidemiological study, France (1985-1991). Médecine et Maladies Infectieuses 1995; 25: 584-593.
26. Smith I, et al. High case-fatality rates of meningococcal disease in Western Norway caused by serogroup C strains belonging to both sequence type (ST)-32 and ST-11 complexes, 1985-2002. Epidemiology and Infection 2006; 134: 1195-1202.
27. Dominguez A, et al. The case-fatality rate of meningococcal disease in Catalonia, 1990-1997. Scandinavian Journal of Infectious Diseases 2004; 36: 274-279. (Pubitemid 38720144)
28. Nonell F, Sobrino J, Torres M. On meningococcal disease, its prognosis, and undernotification of the Public Health Service. Archives of Internal Medicine 2000; 160: 2219-2220.
29. Radetsky M. Oral antibiotics and outcome in meningococcemia. Archives of Internal Medicine 2000; 160: 2220-2223.
30. Wang VJ, et al. Antibiotic treatment of children with unsuspected meningococcal disease. Archives of Pediatrics & Adolescent Medicine 2000; 154: 556-560.
31. Barquet N, et al. Prognostic factors in meningococcal disease. Development of a bedside predictive model and scoring system. Barcelona Meningococcal Disease Surveillance Group. Journal of the American Medical Association 1997; 278: 491-496.
32. van Deuren M, Brandtzaeg P. Parents' and GPs' key role in diagnosis of meningococcal septicaemia. Lancet 2000; 356: 954-955.
33. Norgard B, et al. Pre-hospital parenteral antibiotic treatment of meningococcal disease and case fatality : A Danish population-based cohort study. Journal of Infection 2002; 45: 144-151.
34. Andersen J, et al. Surveillance of cases of meningococcal disease associated with military recruits studied for meningococcal carriage. Scandinavian Journal of Infectious Diseases 2000; 32: 527-531.
35. Bhalla IP, Dutta SB, Kuppuswamy G. Meningococcal meningitis in a military training centre in Hyderabad. Journal of Association of Physicians of India 1972; 20: 177-182.
36. Knights HT. Meningococcal meningitis in New Zealand with special reference to carrier rates in military trainees. New Zealand Medical Journal 1972; 76: 16-22.
37. Mossong J, et al. Social contacts and mixing patterns relevant to the spread of infectious diseases. PLoS Medicine 2008; 5: E74.